UK markets open in 6 hours 20 minutes

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.78-0.22 (-1.69%)
At close: 04:00PM EDT
12.78 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
458
40,000
0
Cost of revenue
-
0
346
0
-
Gross profit
-
0
112
40,000
-
Operating expenses
Research development
11,370
17,216
49,283
79,406
44,505
Selling general and administrative
61,198
50,353
26,579
33,907
29,772
Total operating expenses
73,192
66,465
66,228
97,683
66,010
Operating income or loss
-73,192
-66,465
-66,116
-57,683
-66,010
Interest expense
3,350
2,057
521
340
35
Total other income/expenses net
715
1,866
-4,632
2,422
924
Income before tax
-62,365
-53,895
-68,448
-55,587
-65,000
Income tax expense
1,055
474
253
-18
146
Income from continuing operations
-63,420
-54,369
-68,701
-55,569
-65,146
Net income
-63,420
-54,369
-68,701
-55,569
-65,146
Net income available to common shareholders
-63,420
-54,369
-68,701
-55,569
-65,146
Basic EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Diluted EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Basic average shares
78,105
79,268
66,134
59,149
32,867
Diluted average shares
78,105
79,268
66,134
59,149
32,867